Introduction
SRS
BRAIN METASTASES
Clinical trial data comparing outcomes after administration of stereotactic radiosurgery (SRS) or whole‐brain radiotherapy (WBRT) to patients with brain metastases (BM) suggest that SRS better preserves cognitive function and quality of life without negatively impacting overall survival. Here, we estimate the maximum number of BM that can be treated using single and multi‐session SRS while limiting the dose of radiation delivered to normal brain tissue to that associated with WBRT.